Perbedaan Star Pacific Tbk dan Brigit Biofarmaka Teknologi Tbk.: Star Pacific Tbk diperdagangkan di Rp250 (kapitalisasi pasar 278,56 M, volume 24 jam 813,5 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Star Pacific Tbk lebih besar dari sisi kapitalisasi pasar, dan Star Pacific Tbk lebih aktif diperdagangkan (813,5 rb vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LPLI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 278,56 M | 167,37 M |
Volume | 813,5 rb | 96,7 rb |
Lot | 8,14 rb | 967 |
Perputaran | 204,32 jt | 23,82 jt |
Harga Rata-rata | 251,17 | 246,34 |
Nilai Transaksi | 204,32 jt | 23,82 jt |
Harga Ekuilibrium Indikatif | 250 | 248 |
Volume Ekuilibrium Indikatif | 70 | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Star Pacific Tbk (the Company), was established under the name of PT Asuransi Lippo Jiwa Sakti based on Deed No. 301 dated May 28, 1983 of Misahardi Wilamarta, S.H., a notary in Jakarta, which was amended by Deed No. 130 dated August 10, 1983 by the same notary, concerning the change of the Company's name to PT Asuransi Lippo Life. Furthermore, the Company's name was again changed to Lippo E-Net Tbk based on Deed No. 87 dated June 23, 2000 of Misahardi Wilamarta, S.H., a notary in Jakarta.
Selengkapnya di halaman LPLI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →